L‐Carnitine Suppresses Loss of Skeletal Muscle Mass in Patients With Liver Cirrhosis

Liver cirrhosis (LC) is a major cause of secondary sarcopenia. Sarcopenia makes the prognosis worse; thus, novel therapeutic options for sarcopenia in patients with LC are urgently required as they are currently limited. In this retrospective study, 158 patients with LC were screened, and 35 of thos...

詳細記述

保存先:
書誌詳細
出版年:Hepatol Commun
主要な著者: Ohara, Masatsugu, Ogawa, Koji, Suda, Goki, Kimura, Megumi, Maehara, Osamu, Shimazaki, Tomoe, Suzuki, Kazuharu, Nakamura, Akihisa, Umemura, Machiko, Izumi, Takaaki, Kawagishi, Naoki, Nakai, Masato, Sho, Takuya, Natsuizaka, Mitsuteru, Morikawa, Kenichi, Ohnishi, Shunsuke, Sakamoto, Naoya
フォーマット: Artigo
言語:Inglês
出版事項: John Wiley and Sons Inc. 2018
主題:
Original Articles
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC6078216/
https://ncbi.nlm.nih.gov/pubmed/30094402
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/hep4.1207
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料